Fineline Cube

Follow:
14483 Articles
Policy / Regulatory

China’s NHC and 13 Bureaus Launch Campaign to Rectify Pharmaceutical and Medical Services Practices

Company

Bayer Q1 2023 Financial Report: Sales Dip Amid Regional Challenges and COVID-19 Impact

CompanyDrug

Wuhan Institute’s Hexavalent Rotavirus Vaccine on Track for Priority Review by CDE

CompanyDrug

Kintor Pharmaceutical’s KX-826 Shows Promise in Phase II Study for Male Androgenetic Alopecia

CompanyDeals

ZhenGe Biotech Partners with NNIT for Advanced Digitalization in Drug Development

DrugLegal / IP

CNIPA Releases Patent Linkage Decisions, Paving Way for Generic Drugs in China

CompanyDrug

Guangdong Taienkang’s CKBA Ointment for Vitiligo Accepted for Review by China’s NMPA

CompanyDrug

Mabwell’s B7-H3 Targeting ADC 7MW3711 Accepted for Review by China’s NMPA

CompanyDrug

CStone Pharmaceuticals’ Partner Servier Secures EU Approvals for IDH1 Inhibitor Tibsovo

CompanyDrug

Innovent Biologics’ Mazdutide Showcases Weight Loss Efficacy in Phase II Study for Chinese Adults

Policy / Regulatory

Beijing Medical Insurance Bureau Announces Key Healthcare Initiatives and BMI Expansion

CompanyDrug

Joincare Pharmaceutical Receives NMPA Approval for Triptorelin Microspheres for Prostate Cancer